⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RLAY News
Relay Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
RLAY
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies
globenewswire.com
RLAY
Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular Anomalies
globenewswire.com
RLAY
Form 8-K
sec.gov
RLAY
Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate Updates
globenewswire.com
RLAY
Leo Terrell, Chair of the U.S. Department of Justice Task Force to Combat Antisemitism, Makes Major Announcement on Combating Extremism at NYC Summit
globenewswire.com
RLAY
Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026
globenewswire.com
RLAY
Form 8-K
sec.gov
RLAY
PFE
Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer
globenewswire.com
RLAY
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
globenewswire.com
RLAY